IL2RG and neoplasm: To evaluate the in vivo therapeutic efficacy of CAR-T cells, the subcutaneous OCI-Ly3 xenograft tumor model was established in Syrian hamsters with an immune-deficient phenotype caused by knockout of interleukin-2 receptor subunit gamma (IL2RG) (named ZZU001).32